Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis

Clin Rheumatol. 2022 Aug;41(8):2601-2604. doi: 10.1007/s10067-022-06216-w. Epub 2022 May 25.

Valentina Vertui^#^{1

2}, Giovanni Zanframundo^#^{3

4}, Santos Castañeda^{5

6}, Alessandro Biglia^{3

4}, Bianca Lucia Palermo^{3

4}, Ilaria Cavazzana⁷, Federica Meloni^{3

8}, Lorenzo Cavagna^{3

4}

¹ Division of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. valentina.vertui@gmail.com.
² Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy. valentina.vertui@gmail.com.
³ Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy.
⁴ Division of Rheumatology, IRCCS Policlinico S. Matteo Foundation, Pavia, Lombardia, Italy.
⁵ Rheumatology Division, Hospital de La Princesa, c/ Diego de León 62, IIS-IP, Madrid, Spain.
⁶ Catedra UAM-Roche, EPID-Future, Medicine Department, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
⁷ Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy.
⁸ U.O.S. Transplant Center, IRCCS Policlinico S. Matteo Foundation of Pavia, Pavia, Italy.

^# Contributed equally.

No abstract available

Publication types